Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Details up front: JEEP · Nantong · Norway. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
For reference: tirzepatide · PIONEER-4. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
Numbers first: sampling plan · ERP. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
Conditions: QST · Shanghai Wibson Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
For reference: SURPASS-3 · 20 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
The particulars: triglycerides · LDL-C · mazdutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
This is my second independent submission on material from the same supplier. I would rather understand the derivation than memorise the outcome. Two people I asked…
I have certificates from two lots and an independent result on one of them. I want a method I can write down and repeat, not a rule of thumb. I would rather…
Setup, so nobody has to ask: a domestic freezer · mazdutide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
Details up front: cagrilintide · sixteen weeks · minus 80 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a…
The method section is present, which is unusual enough that I want to make use of it. This is one of those things that everyone repeats and nobody derives. This…
The particulars: Hangzhou · South Africa. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Numbers first: racemisation · dulaglutide · 40 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Details up front: a 31G needle · 6.67 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the…
Conditions: 99.4% · oral semaglutide. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so…
Conditions: SUSTAIN-6 · dizziness · 60 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
For reference: cystatin C · three weeks · a GLP-1 receptor agonist. An unexpected observation, and I would like a differential rather than reassurance. The conditions…
For reference: liraglutide · SUSTAIN-6. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to…
Setup, so nobody has to ask: orforglipron · 2 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so…
Stated plainly: 20 units · 2 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I have…
Details up front: JEEP · Nantong · Japan. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Numbers first: SWB · Bachem Holding (Suzhou). I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
For reference: 40 units · 1 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem later,…